Alfredo Antonio Chetta

Quick facts

Phase 3 pipeline

• Beclomethasone Dipropionate/Formoterol Fumarate · Respiratory/Pulmonology
  Beclomethasone dipropionate reduces airway inflammation via glucocorticoid receptor activation, while formoterol fumarate bronchodilates by stimulating beta-2 adrenergic receptors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Alfredo Antonio Chetta portfolio CI brief
• Alfredo Antonio Chetta pipeline updates RSS